Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg

PHILADELPHIA, March 27, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Aspir... Biopharmaceuticals, Generics, FDA Lannett Company, Boehringer Ingelheim, Aggrenox
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news